Ed serves as a venture capitalist at Future Planet Capital and sits on the investment committee for the UK Innovation & Science Seed Fund. He also holds board and observer roles across several companies.
Alex brings investment experience across Future Planet Capital, the UK Innovation and Science Seed Fund, and Midven.
GP
Guy Pengelley
Portfolio Manager
Guy brings investment banking, corporate finance, and portfolio management experience. He is a co-founder of Viresco Group and previously worked at Future Planet Capital, Peel Hunt, and Deloitte UK.
The seed round was co-led by Future Planet Capital, Foresight Group, and Blackfinch Ventures to accelerate growth in space situational awareness.
"As space becomes increasingly essential to our economy, environment and daily lives, it is also becoming more congested and contested. This investment strengthens our ability to protect satellite technology that delivers crucial insights to Earth around the clock, reducing collision risks, and supporting a safer, more sustainable space environment for future generations"
Future Planet Capital led the round as the med-tech startup prepares for international market launches.
"This funding allows AMLo to embark on the next step of our journey with the resources to potentially relieve countless people with early-stage melanoma from the anxiety and follow-up burden that should be reserved for those with higher risk disease. I am delighted to welcome several new investors, and especially to see such strong additional commitment from our previous partners. Our levelling up from an academic spin-out to commercial success is critical to ensure we have the resources to further drive innovation in medical devices across our markets."
The Cambridge biotechnology company has raised £31.4m from investors including M&G and Amadeus Capital Partners to advance its desktop protein printer.
"There’s a fundamental productivity problem in biotech today. A biotech scientist needs to know how to make proteins to design drugs. That’s like expecting a computer scientist to know how to build a computer to design software,"
The Oxford Science Enterprises-led round will support US expansion and continued domestic growth in healthcare.
"I’m delighted our investors have again demonstrated their belief in the vast potential that Navenio can bring by ensuring ‘right person, right place, right time’. Artificial intelligence is one of many technologies making a real-world impact in the health sector, and this investment enables the company to rapidly spearhead international digital transformation."
Future Planet Capital backed the Oxford University spin-out to help hospitals manage infection risks and patient flows.
"Navenio exemplifies our investment thesis; best-in-class innovation from the world’s top university wrapped into a highly commercial product and company with the potential to scale its impact to help billions of lives. Having established partnerships with the NHS, Cleveland Clinic and some of the world’s largest outsourcers, we believe the company is poised to revolutionise healthcare efficiency worldwide. In addition, the core indoor geo-location engine developed at Oxford’s computer science lab, has achieved what competing tech giants in the space have not, and we believe this will be hugely valuable cross-industry."
